title: Cardiac involvement in children with IBD during infliximab therapy.
authors.forename: Maria
authors.initials: M
authors.lastname: Barbato
authors.forename: Mario
authors.initials: M
authors.lastname: Curione
authors.forename: Franca
authors.initials: F
authors.lastname: Viola
authors.forename: Paolo
authors.initials: P
authors.lastname: Versacci
authors.forename: Fabiana
authors.initials: F
authors.lastname: Parisi
authors.forename: Silvia
authors.initials: S
authors.lastname: Amato
authors.forename: Salvatore
authors.initials: S
authors.lastname: Cucchiara
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000000981:diagnostic imaging / Q000209:etiology*; D015150:Echocardiography, Doppler; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006334:Heart Function Tests; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab